1. Home
  2. Clinical Topics
  3. FDA announces July 22-23 meeting to discuss extended-release and long-acting opioid analgesics
Clinical TopicsDrugs and DevicesNewsPain ManagementWeb Exclusives

FDA announces July 22-23 meeting to discuss extended-release and long-acting opioid analgesics

Share

The U.S. Food and Drug Administration announced a joint meeting of the Anesthetic and Life Support Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee Meeting to discuss Risk Evaluation and Mitigation Strategies (REMS) for extended-release and long-acting opioid analgesics. Interested persons may present data, information, or views, orally or in writing, on issues pending before the committee. Read more at http://www.fda.gov/AdvisoryCommittees/Calendar/ucm214816.htm.

Leave a Reply

Your email address will not be published. Required fields are marked *

Fill out this field
Fill out this field
Please enter a valid email address.

cheryl meeGet your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.

NurseLine Newsletter

  • Hidden

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.

Recent Posts